RO91766B1 - Method for treating enterobiasis - Google Patents

Method for treating enterobiasis

Info

Publication number
RO91766B1
RO91766B1 RO118859A RO11885985A RO91766B1 RO 91766 B1 RO91766 B1 RO 91766B1 RO 118859 A RO118859 A RO 118859A RO 11885985 A RO11885985 A RO 11885985A RO 91766 B1 RO91766 B1 RO 91766B1
Authority
RO
Romania
Prior art keywords
administered
days
tablets
sulfur
done
Prior art date
Application number
RO118859A
Other languages
Romanian (ro)
Other versions
RO91766A2 (en
Inventor
Stefan Popp
Original Assignee
Stefan Popp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stefan Popp filed Critical Stefan Popp
Priority to RO118859A priority Critical patent/RO91766B1/en
Publication of RO91766A2 publication Critical patent/RO91766A2/en
Publication of RO91766B1 publication Critical patent/RO91766B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Metoda de tratament al enterobiozei, conform inventiei, consta în aceea ca tratamentul se face în trei reprize, în prima se administreaza, timp de 4 zile, timol conditionat în tablete, ce se dau alternativ cu tablete enterosolubile, intervalul dintre administrarile celor doua feluri de tablete fiind de 1 h, în a 5-a zi se administreaza sulfat de sodiu si vitamina C si se face o clisma apoasa cu procaina si clorura de sodiu, a 2-a repriza se face dupa 7 zile si consta în administrarea de tablete de sulf obisnuite si enterosolubile, dupa schema de mai sus, urmata de o clisma ce contine etanol, iar repriza a 3-a se face tor dupa 7 zile, cu tribromfenolat de bismut, care se administraza dupa schema de mai sus.The method of treatment of enterobiosis according to the invention consists in the fact that the treatment is done in three halves, the first is administered for 4 days, tablet-conditioned timol, alternatively with enteric-coated tablets, the interval between administrations of the two types of tablets being 1 hour, on day 5, sodium sulfate and vitamin C are administered and an aqueous enema is made with procaine and sodium chloride, the 2nd half is done after 7 days and consists of the administration of tablets sulfur and enterosoluble sulfur, according to the above scheme, followed by an ethanol-containing enema, and the third step is made after 7 days with bismuth tribromophenolate, which is administered as above.

RO118859A 1985-05-24 1985-05-24 Method for treating enterobiasis RO91766B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO118859A RO91766B1 (en) 1985-05-24 1985-05-24 Method for treating enterobiasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO118859A RO91766B1 (en) 1985-05-24 1985-05-24 Method for treating enterobiasis

Publications (2)

Publication Number Publication Date
RO91766A2 RO91766A2 (en) 1987-05-15
RO91766B1 true RO91766B1 (en) 1987-05-31

Family

ID=20117261

Family Applications (1)

Application Number Title Priority Date Filing Date
RO118859A RO91766B1 (en) 1985-05-24 1985-05-24 Method for treating enterobiasis

Country Status (1)

Country Link
RO (1) RO91766B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103554070A (en) * 2013-11-08 2014-02-05 李玉成 Ascorbic acid bismuth oxide, preparation method and application of ascorbic acid bismuth oxide

Also Published As

Publication number Publication date
RO91766A2 (en) 1987-05-15

Similar Documents

Publication Publication Date Title
FI943805A0 (en) Use of substituted adenine derivatives in the treatment of multiple sclerosis
OA08581A (en) Treatment of diseases caused by retroviruses.
NO156373C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FURO- (3,4-C) -PYRIDINE DERIVATIVES.
ES2125233T3 (en) TREATMENT OF HUMAN RETROVIRAL INFECTIONS WITH 2 ', 3'-DIDESOXYINOSINE.
BE890024A (en) TRICYCLIC IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
EP0151989A3 (en) Means for the treatment of cardiac diseases
NO161802C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FURO (3,4-C) PYRIDINE DERIVATIVES.
GR3034186T3 (en) 3,4-diarylchromans for treatment of dermatitis
IL66496A0 (en) Sulfur-substituted phenoxypyridines having antiviral activity,process for their production and pharmaceutical compositions containing them
NO155665C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5,6,7,7A-TETRAHYDRO-4H-THIENO- (3,2-C) -PYRIDIN-2-ON DERIVATIVES.
IT8848251A0 (en) COMPOUNDS RELATED TO ACETOZOLAMMI DE WITH CARBON ANHYDRASE INHIBITING ACTIVITY, PARTICULARLY USEFUL IN THE TREATMENT OF GLAUCOMA
IT1189298B (en) PROCEDURE FOR THE PRODUCTION OF DERMATAN-SULPHATE AND EPARAN-SULPHATE MINOGLICANS GLYCOS SUBSTANTIALLY PURE AND THEIR PHARMACEUTICAL USE
GB2099008B (en) Enzymatic process for the treatment of xanthan gums to improve the filtrability of their aqueous solutions
RO91766B1 (en) Method for treating enterobiasis
FR2564106B1 (en) FACTOR IX EXPRESSION VECTORS, CELLS TRANSFORMED BY THESE VECTORS, AND PROCESS FOR THE PREPARATION OF FACTOR IX.
DE3569673D1 (en) Use of saccharomyces yeasts for the manufacture of a medicament for preventing or treating pseudo-membranous colitis
ES8802400A1 (en) Method and compositions for use in the treatment of fireblight.
ES8503922A1 (en) Eye lotion composition based on chondroitin sulfate A.
NO854277L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 6-PHENETYLAMINOALKYL-7-HYDROXY-FURO- (3,4-C) -PYRIDINE DERIVATIVES.
NO161917C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF TIENO AND FURO (2,3-C) PYROLES.
AU551108B2 (en) Analgesic potentiation of zomepirac with butorphanol
DK174584D0 (en) PENEMES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE, AND PROCEDURES FOR PRODUCING THEREOF
NO166366C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOALKAN (1,2-C: 4,3-C ') DIPYRAZOLES.
IT1211103B (en) MEDICALLY SUBSTANCE FOR TOPICAL USE FOR THE TREATMENT OF DISEASES CAUSED BY SEBORRHEA ON HUMAN HAIR.
IT1145989B (en) PHARMACEUTICAL COMPOUND CONTAINING 1.2.3.CARBOXYPROPIONYL OXYLETH 2 METHYL 5 NITROIMIDAZOLE AS A THERAPEUTIC PEOPLE ACTIVE AGAINST DISEASES CAUSED BY ANAEROBIC GERMS